Skip to main content

Table 1 Positive genetic association studies with acute lung injury/acute respiratory distress syndrome susceptibility and/or outcome (by year of publication)

From: A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury

Gene

Associated variant(s)a

Sample size (case/control)

Sample size (cohort)

Phenotype(s)

Population

Reference (year)

SFTPB

T/C +1580

52:46

 

ARDS

European

[21] (2000)

IL-6

G/C -174

 

96 ARDS

Mortality

European

[22] (2002)

ACE

I/D intron 16

96:2,168

 

ARDS, mortality

European

[23] (2002)

SFTPB

T/C +1580

 

402 CAP

ARDS

Multiethnic

[24] (2004)

SFTPB

Intron 4 TR

 

189 at risk of ARDS

ARDS

Multiethnic

[25] (2004)

PBEF

T/G -1001 and haplotype

87:84

 

ALI

European

[26] (2005)

MBL2

Haplotypes

569:1,188

 

SARS

Chinese

[27] (2005)

IL-6

Gene-wide haplotypes

 

228 SIRS

ALI, need of MV

European

[28] (2005)

IL-6

Haplotype

98:84

 

ALI

European

[29] (2005)

TNF

G/A -308

212:441

 

ARDS, mortality

European

[30] (2005)

VEGF

C/T +936

117:240

 

ARDS, severity

European

[31] (2005)

MYLK

Multiple SNPs and haplotypes

138:146

 

ALI

Multiethnic

[32] (2006)

IL-10

A/G -1082

211:429

 

ARDS, severity

European

[33] (2006)

ACE

I/D intron 16

101:348

 

ARDS mortality

Chinese

[34] (2006)

MIF

Haplotypes

151:173

 

ALI

Multiethnic

[35] (2007)

PBEF

T/G -1001 and haplotype

375:787

 

ARDS, mortality

European

[36] (2007)

NRF2

C/A -617

 

90 major trauma

ALI

Multiethnic

[37] (2007)

CXCL2

-665 TR

 

183 severe sepsis

ARDS mortality

European

[38] (2007)

MBL2

Gly54Asp

212:442

 

ARDS, severity

European

[39] (2007)

ACE

I/D intron 16

84:200

 

ARDS mortality

European

[40] (2007)

NFKBIA

Haplotype

382:828

 

ARDS

European

[41] (2007)

NFKB1

Ins/del ATTG -94

 

103 ARDS

Severity

European

[42] (2007)

VEGF

C/T +936 and haplotype

 

394 ARDS

Mortality

European

[43] (2007)

PLAU

Gene-wide haplotype

175:252

 

ALI, severity

European

[44] (2008)

MYLK

3 variants and multiple haplotypes

 

273 major trauma

ALI

Multiethnic

[45] (2008)

MBL2

Haplotypes

 

848 CAP

ARDS

European

[46] (2008)

IL-6

Gene-wide haplotype

67:96

 

ALI

European

[47] (2008)

IL-10

A/G -1082

 

100 severe multiple trauma

ARDS

European

[48] (2008)

F5

Arg506Gln

 

106 ARDS

Mortality

European

[49] (2008)

  1. aNames are those originally reported in the corresponding reference. Ins/del, insertion-deletion polymorphism. ACE, angiotensin-converting enzyme; ALI, acute lung injury; ARDS, acute respiratory distress syndrome; CAP, community-acquired pneumonia; CXCL2, chemokine CXC motif ligand 2; F5, coagulation factor V; IL-6, interleukin-6; IL-10, interleukin-10; MBL2, mannose-binding lectin-2; MIF, macrophage migration inhibitory factor; MV, mechanical ventilation; MYLK, myosin light-chain kinase; NFKB1, nuclear factor kappa light polypeptide gene enhancer in B cells; NFKBIA, nuclear factor kappa light polypeptide gene enhancer in B cells inhibitor alpha; NRF2, nuclear factor erythroid-derived 2 factor; PBEF, pre-B cell-enhancing factor; PLAU, plasminogen activator urokinase; SARS, severe acute respiratory syndrome; SFTPB, surfactant pulmonary-associated protein B; SIRS, systemic inflammatory response syndrome; SNP, single-nucleotide polymorphism; TNF, tumor necrosis factor; TR, tandem repeat (polymorphism); VEGF, vascular endothelial growth factor.